Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Multiplex Assay Market, by Product
1.4.2 North America Multiplex Assay Market, by Type
1.4.3 North America Multiplex Assay Market, by End User
1.4.4 North America Multiplex Assay Market, by Application
1.4.5 North America Multiplex Assay Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Approvals and Trials
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, May – 2021, Oct) Leading Players
Chapter 4. North America Multiplex Assay Market by Product
4.1 North America Reagents & Consumables Market by Country
4.2 North America Instruments & Accessories Market by Country
4.3 North America Software & Services Market by Country
Chapter 5. North America Multiplex Assay Market by Type
5.1 North America Protein Based Multiplex Assays Market by Country
5.2 North America Nucleic Acid-Based Multiplex Assay Market by Country
5.3 North America Others Market by Country
Chapter 6. North America Multiplex Assay Market by End User
6.1 North America Pharmaceutical & Biotechnology Companies Market by Country
6.2 North America Research Institutes Market by Country
6.3 North America Clinical Laboratories Market by Country
6.4 North America Hospitals Market by Country
Chapter 7. North America Multiplex Assay Market by Application
7.1 North America Research & Development Market by Country
7.2 North America Clinical Diagnostics Market by Country
7.3 North America Companion Diagnostics Market by Country
Chapter 8. North America Multiplex Assay Market by Country
8.1 US Multiplex Assay Market
8.1.1 US Multiplex Assay Market by Product
8.1.2 US Multiplex Assay Market by Type
8.1.3 US Multiplex Assay Market by End User
8.1.4 US Multiplex Assay Market by Application
8.2 Canada Multiplex Assay Market
8.2.1 Canada Multiplex Assay Market by Product
8.2.2 Canada Multiplex Assay Market by Type
8.2.3 Canada Multiplex Assay Market by End User
8.2.4 Canada Multiplex Assay Market by Application
8.3 Mexico Multiplex Assay Market
8.3.1 Mexico Multiplex Assay Market by Product
8.3.2 Mexico Multiplex Assay Market by Type
8.3.3 Mexico Multiplex Assay Market by End User
8.3.4 Mexico Multiplex Assay Market by Application
8.4 Rest of North America Multiplex Assay Market
8.4.1 Rest of North America Multiplex Assay Market by Product
8.4.2 Rest of North America Multiplex Assay Market by Type
8.4.3 Rest of North America Multiplex Assay Market by End User
8.4.4 Rest of North America Multiplex Assay Market by Application
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.6 SWOT Analysis
9.2 Bio-Rad laboratories, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Approvals and Trials:
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.4 Seegene, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent strategies and developments:
9.4.4.1 Approvals and Trials:
9.4.4.2 Geographical Expansions:
9.5 Randox Laboratories Limited
9.5.1 Company Overview
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.7 Qiagen N.V.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.8 DiaSorin S.p.A. (Luminex Corporation)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.8.5.2 Approvals and Trials:
9.9 Abcam plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.10. Meso Scale Diagnostics LLC
9.10.1 Company Overview
Unique Offerings 